Logo image of EWL.DE

EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:EWL - US28176E1082 - Common Stock

72.85 EUR
+0.44 (+0.61%)
Last: 1/22/2026, 7:00:00 PM
Fundamental Rating

7

Taking everything into account, EWL scores 7 out of 10 in our fundamental rating. EWL was compared to 67 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making EWL a very profitable company, without any liquidiy or solvency issues. EWL is valied quite expensively at the moment, while it does show a decent growth rate. These ratings could make EWL a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year EWL was profitable.
  • EWL had a positive operating cash flow in the past year.
  • EWL had positive earnings in each of the past 5 years.
  • Each year in the past 5 years EWL had a positive operating cash flow.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 10.31%, EWL belongs to the top of the industry, outperforming 89.55% of the companies in the same industry.
  • The Return On Equity of EWL (13.40%) is better than 76.12% of its industry peers.
  • EWL has a better Return On Invested Capital (9.83%) than 76.12% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EWL is above the industry average of 9.84%.
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROIC 9.83%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • EWL has a better Profit Margin (23.25%) than 92.54% of its industry peers.
  • In the last couple of years the Profit Margin of EWL has grown nicely.
  • The Operating Margin of EWL (27.73%) is better than 95.52% of its industry peers.
  • EWL's Operating Margin has been stable in the last couple of years.
  • EWL's Gross Margin of 78.19% is amongst the best of the industry. EWL outperforms 92.54% of its industry peers.
  • EWL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

10

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
  • EWL has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for EWL has been reduced compared to 5 years ago.
  • EWL has a better debt/assets ratio than last year.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • EWL has an Altman-Z score of 12.42. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 12.42, EWL belongs to the best of the industry, outperforming 95.52% of the companies in the same industry.
  • EWL has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
  • EWL has a Debt to FCF ratio of 0.75. This is amongst the best in the industry. EWL outperforms 92.54% of its industry peers.
  • A Debt/Equity ratio of 0.06 indicates that EWL is not too dependend on debt financing.
  • The Debt to Equity ratio of EWL (0.06) is better than 86.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Altman-Z 12.42
ROIC/WACC0.99
WACC9.96%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • EWL has a Current Ratio of 4.00. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • EWL has a Current ratio of 4.00. This is amongst the best in the industry. EWL outperforms 91.04% of its industry peers.
  • EWL has a Quick Ratio of 3.29. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • EWL's Quick ratio of 3.29 is amongst the best of the industry. EWL outperforms 91.04% of its industry peers.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.29
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • EWL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.75%.
  • Measured over the past 5 years, EWL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
  • EWL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.67%.
  • The Revenue has been growing slightly by 4.58% on average over the past years.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%

3.2 Future

  • Based on estimates for the next years, EWL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.40% on average per year.
  • The Revenue is expected to grow by 8.47% on average over the next years. This is quite good.
EPS Next Y1.51%
EPS Next 2Y6.17%
EPS Next 3Y7.9%
EPS Next 5Y9.4%
Revenue Next Year4.68%
Revenue Next 2Y7.17%
Revenue Next 3Y8.07%
Revenue Next 5Y8.47%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 33.26, which means the current valuation is very expensive for EWL.
  • Compared to the rest of the industry, the Price/Earnings ratio of EWL is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 27.32, EWL is valued a bit more expensive.
  • Based on the Price/Forward Earnings ratio of 28.96, the valuation of EWL can be described as expensive.
  • 61.19% of the companies in the same industry are cheaper than EWL, based on the Price/Forward Earnings ratio.
  • EWL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.32.
Industry RankSector Rank
PE 33.26
Fwd PE 28.96
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • EWL's Enterprise Value to EBITDA is on the same level as the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as EWL.
Industry RankSector Rank
P/FCF 62.06
EV/EBITDA 25.12
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EWL does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)21.99
PEG (5Y)4.67
EPS Next 2Y6.17%
EPS Next 3Y7.9%

0

5. Dividend

5.1 Amount

  • No dividends for EWL!.
Industry RankSector Rank
Dividend Yield 0%

EDWARDS LIFESCIENCES CORP

FRA:EWL (1/22/2026, 7:00:00 PM)

72.85

+0.44 (+0.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30
Earnings (Next)02-10
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap42.27B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts79.52
Price Target84.6 (16.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)3.56%
PT rev (3m)10.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.28%
EPS NY rev (1m)0.07%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)0.25%
Revenue NQ rev (3m)0.25%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.99%
Valuation
Industry RankSector Rank
PE 33.26
Fwd PE 28.96
P/S 8.43
P/FCF 62.06
P/OCF 48.81
P/B 4.86
P/tB 6.79
EV/EBITDA 25.12
EPS(TTM)2.19
EY3.01%
EPS(NY)2.52
Fwd EY3.45%
FCF(TTM)1.17
FCFY1.61%
OCF(TTM)1.49
OCFY2.05%
SpS8.64
BVpS14.98
TBVpS10.72
PEG (NY)21.99
PEG (5Y)4.67
Graham Number27.17
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROCE 13.97%
ROIC 9.83%
ROICexc 14.65%
ROICexgc 23.24%
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
FCFM 13.59%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Debt/EBITDA 0.33
Cap/Depr 138.79%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 56.86%
Profit Quality 58.45%
Current Ratio 4
Quick Ratio 3.29
Altman-Z 12.42
F-Score6
WACC9.96%
ROIC/WACC0.99
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y1.51%
EPS Next 2Y6.17%
EPS Next 3Y7.9%
EPS Next 5Y9.4%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.68%
Revenue Next 2Y7.17%
Revenue Next 3Y8.07%
Revenue Next 5Y8.47%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13%
EBIT Next 3Y12.27%
EBIT Next 5Y12.3%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%

EDWARDS LIFESCIENCES CORP / EWL.DE FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.


What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


What is the profitability of EWL stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.


What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 33.26 and the Price/Book (PB) ratio is 4.86.